-+ 0.00%
-+ 0.00%
-+ 0.00%

The US plans to liberalize competition in the nephropathy treatment market, and the two major dialysis leaders, Davita and Fresenius Medical, rapidly weakened.

Zhitongcaijing·10/20/2026 16:17:05
Listen to the news
The US plans to liberalize competition in the nephropathy treatment market, and the two major dialysis leaders, Davita and Fresenius Medical, rapidly weakened.